Fidelity Investments
PALI icon

Fidelity Investments’s Palisade Bio PALI Stock Holding History

Fidelity Investments’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10
Closed -$24 – 5528
2025
Q4 		$24 Buy
+10
New +$19 ﹤0.01% 5346
2024
Q2 		– Hold
0
– -$1 – 5569
2024
Q1 		– Sell
-3
Closed -$21 – 5334
2023
Q4 		$22 Buy
+3
New +$26 ﹤0.01% 5190
2022
Q4 		– Sell
-27
Closed -$2K – 5522
2022
Q3 		$2K Buy
+27
New +$5.72K ﹤0.01% 4574
2021
Q1 		– Hold
0
– – – 4388
2020
Q4 		– Hold
0
– – – 4172
2018
Q4 		– Hold
0
– – – 3966
2018
Q3 		– Hold
0
– – – 3721

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Fidelity Investments's PALI Position: Q1 2026 in Review

Fidelity Investments sold out of Palisade Bio (PALI) in Q1 2026, closing a stake of 10 shares — an estimated $24 sold.

Fidelity Investments first reported a position in PALI in Q3 2022 and held it in 3 quarters. The position peaked at $2K in Q3 2022. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Fidelity Investments reported no remaining Palisade Bio position as of Q1 2026 after selling out during the quarter.
  • Fidelity Investments sold 10 Palisade Bio shares in Q1 2026, an estimated $24.
  • Fidelity Investments first reported a position in Palisade Bio in Q3 2022 and held it in 3 quarters.
  • Fidelity Investments's Palisade Bio position peaked at $2K in Q3 2022.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.